Transurethral Needle Ablation (TUNA&lt;sup&gt;TM&lt;/sup&gt;)

Chapple, Christopher R.; Issa, MutaM.; Woo, Henry H.

doi:10.1159/000019832

Cited by 45 publications

(9 citation statements)

References 27 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…However, the TEMPRO system has several advantages. In addition, TUNA is not suitable for prostates larger than 75 ml (Chapple, Issa, & Woo, 1999). In addition, endoscopy is not needed prior to the TEMPRO thermoablation procedure unlike TUMT (D'Ancona et al, 1999).…”

Section: Discussionmentioning

confidence: 99%

Effect of bipolar radiofrequency thermotherapy on benign prostate hyperplasia

Diri

Gül

2019

Andrologia

View full text Add to dashboard Cite

| INTRODUC TI ONBenign prostatic hyperplasia (BPH) is the most common type of benign neoplasms in the male population. It affects approximately 50% and 90% men >60 and at around 85 years of age respectively (Lim, 2017). BPH can have a major effect on the quality of life because of symptoms, such as urinary urgency, frequency, nocturia, incomplete voiding of urine, weak urinary flow and hesitancy. The treatment options for BPH include conventional medications, such as alpha-1 blockers, 5-alpha reductase inhibitors and transurethral resection of the prostate (TURP; Foster et al., 2018). Although medical treatment slows the progression of BPH, approximately one in 10 patient expe-Abstract This study aims to evaluate the safety and efficacy of the new bipolar radiofrequency thermotherapy device (TEMPRO) in treating patients with benign prostate hyperplasia (BPH). Between December 2017 and November 2018, 72 male patients with BPH were included. All patients completed the International Prostate Symptom Score (IPSS) and International Index of Erectile Function-5 (IIEF-5) questionnaires. Physical examinations were performed, and prostate volume, prostatic urethral length andpost-voiding residual urine (PVR) were measured using ultrasound. Uroflowmetry was used to calculate the maximum flow rate of urination (Qmax). Bipolar radiofrequency thermotherapy was applied with TEMPRO system containing a 16Fr applicator. All patients were re-evaluated at 6 months post-operatively. The mean age of the patients was 63.22 ± 6.68 years. All patients were treated with local anaesthesia, and three patients were unable to complete the procedure. The median (IQR) visual analogue scale score was 1 (0-3) at 6 hr post-operatively. After 6 months, significant improvements were observed in the IPSS, QoL, Qmax and PVR values of the patients (p < .001 for Qmax, IPSS and QoL; p = .03 for PMR). The success rate of the procedure was similar between patients with prostate volumes <70 and >70 ml. Due to its low rate of complication, the TEMPRO © treatment is effective in treating BPH, especially among aged patients and those with serious symptoms. K E Y W O R D Sbenign prostate hyperplasia, radiofrequency, thermotherapy, treatment How to cite this article: Diri MA, Gul M. Effect of bipolar radiofrequency thermotherapy on benign prostate hyperplasia.

show abstract

Section: Discussionmentioning

confidence: 99%

Effect of bipolar radiofrequency thermotherapy on benign prostate hyperplasia

Diri

Gül

2019

Andrologia

View full text Add to dashboard Cite

show abstract

“…During the last decade, a number of less invasive treatment options for elderly men suffering from lower urinary tract symptoms due to benign prostatic hyperplasia (BPH) have been developed [1, 2, 3, 4]. One of the driving forces behind this development was the intra– and postoperative morbidity of transurethral resection of the prostate (TURP) [5, 6, 7, 8, 9].…”

Section: Introductionmentioning

confidence: 99%

Two–Year Results of Transurethral Resection of the Prostate versus Four ‘Less Invasive’ Treatment Options

Schatzl¹,

Madersbacher²,

Djavan³

et al. 2000

European Urology

106

View full text Add to dashboard Cite

“…Patients undergoing TUNA require no hospitalisation. Analysis of clinical outcome of TUNA in a number of non-randomised studies confirmed subjective and objective improvement observed in the RCT from Bruskewitz and co-workers [92]but an average failure rate of 20.1% (range: 5–42) was reported suggesting that clinical response might not be as durable as desired [93]. …”

Section: Resultsmentioning

confidence: 81%

“…Results of several non-randomised studies confirmed the clinical benefit observed in the randomised study from Bruskewitz and co-workers [92]although a significant variability was observed. Failure rate in non-randomised studies is in the range of 20% [93]. …”

Section: Discussionmentioning

confidence: 99%

Invasive and Minimally Invasive Treatment Modalities for Lower Urinary Tract Symptoms: What Are the Relevant Differences in Randomised Controlled Trials?

Tubaro¹,

Vicentini²,

Renzetti³

et al. 2000

Eur Urol

View full text Add to dashboard Cite

Transurethral Needle Ablation (TUNA<sup>TM</sup>)

Cited by 45 publications

References 27 publications

Effect of bipolar radiofrequency thermotherapy on benign prostate hyperplasia

Effect of bipolar radiofrequency thermotherapy on benign prostate hyperplasia

Two–Year Results of Transurethral Resection of the Prostate versus Four ‘Less Invasive’ Treatment Options

Invasive and Minimally Invasive Treatment Modalities for Lower Urinary Tract Symptoms: What Are the Relevant Differences in Randomised Controlled Trials?

Contact Info

Product

Resources

About

Transurethral Needle Ablation (TUNA<sup>TM</sup>)

Cited by 45 publications

References 27 publications

Effect of bipolar radiofrequency thermotherapy on benign prostate hyperplasia

Effect of bipolar radiofrequency thermotherapy on benign prostate hyperplasia

Two&ndash;Year Results of Transurethral Resection of the Prostate versus Four &lsquo;Less Invasive&rsquo; Treatment Options

Invasive and Minimally Invasive Treatment Modalities for Lower Urinary Tract Symptoms: What Are the Relevant Differences in Randomised Controlled Trials?

Contact Info

Product

Resources

About

Two–Year Results of Transurethral Resection of the Prostate versus Four ‘Less Invasive’ Treatment Options